Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $7.40 +2.78%
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- BofA maintains underperform ratings on six BDC stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
